Spectrum Pharmaceuticals Inc.

(SPPI) Trade

By |

Profile

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Contact Information

Website: www.sppirx.com
Email: InvestorRelations@sppirx.com
Main Phone: +1 702 835-6300
Address: 11500 South Eastern Avenue
Address 2: Suite 240
State: NV
City / Town: Henderson
Country: USA
Postal Code: 89052

Issuer Information

Exchange: NGS
CEO: Joseph W. Turgeon
Employees: 235
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Contact Information

Website: www.sppirx.com
Email: InvestorRelations@sppirx.com
Main Phone: +1 702 835-6300
Address: 11500 South Eastern Avenue
Address 2: Suite 240
State: NV
City / Town: Henderson
Country: USA
Postal Code: 89052

Issuer Information

Exchange: NGS
CEO: Joseph W. Turgeon
Employees: 235
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.45 $ -0.2 (-2.61%)
Last Price 7.45 Change $ -0.2 Change % -2.61 Tick N/A
Bid 7.30 Bid Size 1,000.00 Ask 8.09 Ask Size 5,000.00
Open 7.61 High 7.69 Low 7.40 Prev Close 7.65
Last Trade Volume 1 mi 52 Wk Hi 25.29 52 Wk Low 6.22
Market Cap 834.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 111,963,467.00 EPS (TTM) -1.17 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 55 84
Number of Buys 5 24
Number of Sells 50 60
Net Activity -640625 1945195
Last 10 Buys Shares
Brett L. Scott 1,000
George Tidmarsh 1,000
George Tidmarsh 1,000
Dilip Mehta 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Anthony E. Maida 1,000
Last 10 Sell Shares
Stuart M. Krassner 1,000
Thomas J. Riga 1,000
Raymond Wayne Cohen 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
Rajesh C. Shrotriya 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 33 33 33 33
Low Target Price Estimate 25 25 25 25
Mean Target Price Estimate 29 29 29 29
Standard Deviation 4.08 4.08 4.08 4.08
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1